Precipio, Inc. Common Stock (PRPO) is a publicly traded Healthcare sector company. As of November 10, 2026, PRPO trades at $24.68 with a market cap of $39.74M and a P/E ratio of -36.91. PRPO moved +5.77% today. Year to date, PRPO is -1.31%; over the trailing twelve months it is +16.15%. Its 52-week range spans $3.90 to $33.63. Rallies surfaces PRPO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Precipio revenue rises 8% as Q3 breaks even: Precipio's Q3 2026 revenue rose 8% year over year to $7.3 million, and it broke even versus a $100,000 net loss a year earlier. Adjusted EBITDA fell 20% to $400,000, while operating cash flow reached $600,000.
| Metric | Value |
|---|---|
| Price | $24.68 |
| Market Cap | $39.74M |
| P/E Ratio | -36.91 |
| EPS | $-0.64 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.63 |
| 52-Week Low | $3.90 |
| Volume | 16.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $27.20M |
| Net Income | $-1.22M |
| Gross Margin | 44.11% |
PRPO analyst coverage data. Average price target: $0.00.